Trial intelligence / Profile preview

Sevoflurane Anti-inflammatory Effect in Lung Surgery

NCT02188407Phase 1Completed

Sponsor
University Medical Centre Ljubljana
Start
Jul 2008
Primary completion
Sep 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, open-label trial of sevoflurane in not applicable; "lung injury" is not a specific disease (2 arms), sponsored by University Medical Centre Ljubljana. Primary endpoint: Interleukin 6. Started Jul 2008; status: completed.

02

Drugs

sevoflurane
03

Conditions

not applicable; "lung injury" is not a specific disease

Beyond the preview

Go deeper on NCT02188407.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02188407.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call